Probo Medical Acquires SonoDepot

April 19, 2021

Probo Medical is a leading global provider of medical imaging equipment, parts, repair and service. Terms of the transaction were not disclosed.

Probo Medical notes SonoDepot, founded in 1985, is a St. Cloud, Florida-based third-party service, maintenance, and repair organization with deep specialization in ultrasound equipment. SonoDepot’s team of field service engineers have a long history of supporting hospitals, physician offices and imaging centers across the United States for their ultrasound maintenance, service and sales needs. SonoDepot, led today by Floyd McAuliffe and Jack McAuliffe, also offers ultrasound equipment leasing solutions to its customers.

“We are excited to welcome the SonoDepot team to Probo Medical,” said Michael Asmer, CEO of Probo Medical. “With their deep technical expertise across OEM models, the SonoDepot team has established themselves as one of the premier service and repair businesses in the ultrasound sector. Adding the SonoDepot field service engineers to Probo’s existing service footprint extends Probo as a coast-to-coast third-party service provider and we’re excited to support SonoDepot’s customers with the added-resources of Probo.”

SonoDepot President, Floyd McAuliffe, said, “Partnering with Probo provides SonoDepot with a proven platform and management team that will allow the business to continue to thrive into the future. With Probo’s vast inventory of ultrasound parts, probes and systems, we are excited for the positive impacts this will have on our ability to exceed our customers’ expectations. We would like to express our gratitude to the thousands of sonographers that we’ve had the joy of serving for nearly 40 years, and to our employees that have taken SonoDepot to this level.”

Jack McAuliffe, SonoDepot CEO, added, “We have known the Probo team for many years and see deep alignment, not only with respect to our business interests, but, more importantly, in a common culture that puts the customer and our employees at the center of what we do. We feel very fortunate to serve our customers and to have built the strong relationships we have with our customers over the many years of supporting their ultrasound needs. Our team is enthusiastic to continue that as part of the Probo family.”

Probo Medical is backed by Varsity Healthcare Partners, a lower middle-market private equity investment firm focused on partnering with founders, entrepreneurs and management teams to build leading healthcare services companies.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”